Biocon to host virtual analyst meet on September 4, 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Biocon to host virtual analyst meet on September 4, 2026
  • Session part of Nomura Asian Credit Corporate Day 2026
  • No UPSI to be disclosed during interaction
  • Intimation issued under SEBI Regulation 30(6)
powered bylight_fuzz_icon
49730195

*this image is generated using AI for illustrative purposes only.

Biocon will host a group meeting with analysts and institutional investors on September 4, 2026. The virtual session is part of the Nomura Asian Credit Corporate Day 2026.

The company issued the intimation pursuant to Regulation 30(6) of the SEBI Listing Regulations. Management confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the interaction.

Event Details

Date Event Type Venue
September 4, 2026 Nomura Asian Credit Corporate Day 2026 Group Virtual

Rajesh U. Shanoy, Company Secretary and Compliance Officer, signed the communication dated August 31, 2026. The schedule remains subject to change based on exigencies from investors or the company.

Historical Stock Returns for Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
+0.22%-0.85%-4.73%+5.70%+16.63%0.0%

How might the strategic priorities discussed at the Nomura Asian Credit Corporate Day influence Biocon's capital allocation strategy for FY2027?

What specific updates can investors expect regarding the commercialization timeline of Biocon's key biologic candidates following this interaction?

Will Biocon address its long-term debt restructuring progress and credit rating outlook during the virtual session?

Biocon declares ₹0.50 per share final dividend for FY26

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Biocon declares a final dividend of ₹0.50 per equity share for FY26
  • Shareholders on record as of July 3, 2026 are eligible for the payout
  • The dividend was approved at the AGM held on August 6, 2026
  • Electronic remittance of dividends commenced on August 28, 2026
powered bylight_fuzz_icon
49476952

*this image is generated using AI for illustrative purposes only.

Biocon Limited has commenced the electronic remittance of its final dividend for the financial year ending March 31, 2026. The payout was approved by shareholders at the company’s 48th Annual General Meeting held on August 6, 2026.

The dividend amount has been credited to bank accounts linked with registered demat holdings or folio numbers. Shareholders are advised to verify the credit in their respective accounts.

Dividend Details

The final dividend is fixed at ₹0.50 per equity share. This payout applies to shares held by investors on the record date of July 3, 2026. The face value of each equity share remains at ₹5.

Parameter Detail
Dividend Per Share ₹0.50
Face Value ₹5
Record Date July 3, 2026
Approval Date August 6, 2026
Remittance Date August 28, 2026

Shareholder Instructions

Investors who have not received the dividend credit should contact KFin Technologies Limited, the company’s Registrar and Share Transfer Agent. Future communications regarding this matter must include the shareholder name and Folio number or DPID and Client ID.

Rajesh U. Shanoy, Company Secretary and Compliance Officer, confirmed the remittance in a filing dated August 28, 2026.

Historical Stock Returns for Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
+0.22%-0.85%-4.73%+5.70%+16.63%0.0%

How does Biocon's current dividend yield compare to its historical averages and peer group in the biopharma sector?

Will Biocon maintain this dividend payout ratio in upcoming quarters given the capital-intensive nature of its R&D pipeline?

What impact might this dividend distribution have on Biocon's free cash flow and future investment capacity for new drug developments?

More News on Biocon

1 Year Returns:+16.63%